The Future of Mobile Data in Clinical Trials: Challenges and Opportunities

08/15/19 • 16 min

In this podcast from the 2018 Mobile in Clinical Trials conference, Dr Paul Glimcher, Julius Silver Professor of Neural Science and Physiology at NYU alongside Dr Daniel Karlin, CEO at Healthmode presented on the future of mobile data in clinical trials. Drs Glimcher and Karlin discussed this rapidly evolving space with an emphasis on the barriers and opportunities in the mobile health arena. More specifically: • What are the Barriers to gathering an incorporating Mobile data into clinical trials? • What are the most important new datatypes that are evolving in the Mobile Health space? • How can we use Real World Measurements to identify new classes of clinically relevant endpoints to go beyond Billing Codes? • Can we expect to see large-scale Mobile databases for synthetic use on the model of EMRs and ICD codes? • How should we think of these new classes of data, are they just novel bioindicators or something else? Dr Karlin is returning to Mobile 2019 as co-chair. Speakers: Paul Glimcher, PhD, Julius Silver Professor of Neural Science and Physiology, NYU Daniel Karlin, MD, CEO, Healthmode

Previous Episode

Eli Lilly: How to Launch Multiple Mobile Devices in a Hybrid Setting

In this podcast from the 2018 Mobile in Clinical Trials conference, Eli Lilly's Joseph Kim, Sr Advisor, Clinical Operations and Digital Registry, Digital Health Office | Translational Technology & Innovation, reported on incorporating a variety of mobile devices – including a smart phone, smart insulin pens, connected devices, mifi, and laptops, into a clinical trial. Considerations and lessons learned for: • Connecting all the devices • Implementation differences between traditional vs siteless • Coordinating the equipment; challenges and successes • Lessons learned • What’s next? Speaker: Joseph Kim, Sr Advisor, Clinical Operations and Digital Registry, Digital Health Office | Translational Technology & Innovation, Eli Lilly & Co

Next Episode

A Patient Perspective on Living with Parkinson's Disease and the GDNF Trial

It is estimated that between 7-10 million people, globally have Parkinson's disease. Our guest on Pharma Talk Radio, Lesley Gosden is living with Parkinsons and she is an outstanding patient advocate, who experienced the GDNF clinical trial. In this podcast discussion, our guest will give us an insight into living with Parkinson's, about the GDNF clinical trial, lessons for all stakeholders and in particular how the success rate of clinical trials could be improved from the patient’s point of view. Ms Gosden will be the Keynote patient advocate speaker at the Patients as Partners EU conference taking place in London on January 27th and 28th and for more information, visit theconferenceforum.org. Guest: Lesley Gosden, Patient Advocate Host: Valerie Bowling, Producer, Pharma Talk Radio For more information about the GDNF Trial: Reflections on the GDNF Trial